CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-25 | EW Healthcare Partners, L.P. 10% owner | Sale | −72,925 | $11.09 | $809K | 3,810,835 |
| 2023-08-25 | EW Healthcare Partners, L.P. 10% owner | Sale | −11,731 | $10.45 | $123K | 3,799,104 |
| 2023-08-25 | EW Healthcare Partners, L.P. 10% owner | Sale | −30,000 | $10.67 | $320K | 3,853,760 |
| 2023-08-25 | EW Healthcare Partners, L.P. 10% owner | Sale | −54,656 | $11.19 | $611K | 3,799,104 |
| 2023-08-24 | EW Healthcare Partners, L.P. 10% owner | Sale | −87,100 | $11.54 | $1.0M | 3,935,940 |
| 2023-08-24 | EW Healthcare Partners, L.P. 10% owner | Sale | −52,180 | $10.56 | $551K | 3,883,760 |
| 2023-08-24 | EW Healthcare Partners, L.P. 10% owner | Sale | −139,280 | $14.62 | $2.0M | 3,883,760 |
| 2023-08-23 | EW Healthcare Partners, L.P. 10% owner | Sale | −121,103 | $13.05 | $1.6M | 4,023,040 |
| 2023-08-22 | EW Healthcare Partners, L.P. 10% owner | Sale | −46,778 | $14.62 | $684K | 4,144,143 |
| 2023-07-11 | Zaderej Karen L. Director | Option exercise | +2,000 | 2,000 | ||
| 2023-07-11 | Zaderej Karen L. Director | Option exercise · Restricted Stock Units | −2,000 | 4,000 | ||
| 2023-07-10 | Duker Jay S. President and CEO | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2023-07-10 | Duker Jay S. President and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-07-10 | Lurker Nancy Executive Vice Chair | Grant or award · Restricted Stock Units | +33,334 | 33,334 | ||
| 2023-07-10 | Lurker Nancy Executive Vice Chair | Grant or award · Stock Option (Right to Buy) | +66,666 | 66,666 | ||
| 2023-06-23 | ADAMIS ANTHONY P Director | Option exercise | +2,000 | 2,000 | ||
| 2023-06-23 | ADAMIS ANTHONY P Director | Option exercise · Restricted Stock Units | −2,000 | 4,000 | ||
| 2023-06-20 | GUYER DAVID R Director | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2023-06-20 | GUYER DAVID R Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-20 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 |
Page 22 of 31 · 616 trades